Henry Schein (HSIC) Stock Price, News & Analysis

Company Overview

Henry Schein, Inc. (NASDAQ: HSIC) is a global provider of health care products and services for dental and medical professionals. The company distributes consumable supplies, equipment, pharmaceuticals, vaccines, and other products used by dental practices, physician offices, clinics, and other health care organizations.

In addition to product distribution, Henry Schein provides technology and business solutions designed to support practice operations. Its offerings include practice-management software, digital dentistry solutions, clinical technologies, equipment services, consulting, and other value-added services. The company also serves institutions, laboratories, government agencies, and other health care providers.

Founded in 1932 as a pharmacy in Queens, New York, Henry Schein has grown into a multinational health care solutions company. It serves customers through operations and distribution networks across North America, Europe, Asia-Pacific, and other international markets. The company is headquartered in Melville, New York, and has historically been led by Stanley M. Bergman, who has served as chairman and chief executive officer.

Key Stats

• Today's Range: $87.36 to $88.79
• 50-Day Range: $83.22 to $90.86
• 52-Week Range: $61.94 to $92.18
• Volume: 713,845 shs
• Average Volume: 867,046 shs
• Market Capitalization: $9.85 billion
• P/E Ratio: 25.76
• Dividend Yield: N/A
• Price Target: $92.93
• Consensus Rating: Moderate Buy

Henry Schein Stock Analysis - MarketRank™

Henry Schein scored higher than 42% of companies evaluated by MarketBeat, and ranked 645th out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Henry Schein has received a consensus rating of Moderate Buy. The company's average rating score is 2.53, and is based on no strong buy ratings, 9 buy ratings, 5 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Henry Schein is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Henry Schein has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 10.82%

Earnings Growth

Earnings for Henry Schein are expected to grow by 10.82% in the coming year, from $5.36 to $5.94 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Henry Schein is 25.76, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.15.

Price to Earnings Ratio vs. Sector

The P/E ratio of Henry Schein is 25.76, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.10.

Price to Earnings Growth Ratio

Henry Schein has a PEG Ratio of 1.67. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Henry Schein has a P/B Ratio of 2.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.37% of the float of Henry Schein has been sold short.

Short Interest Ratio / Days to Cover

Henry Schein has a short interest ratio ("days to cover") of 9.05.

Change versus previous month

Short interest in Henry Schein has recently increased by 17.78%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Henry Schein does not currently pay a dividend.

Dividend Growth

Henry Schein does not have a long track record of dividend growth.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.91

News Sentiment

Henry Schein has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Henry Schein this week, compared to 7 articles on an average week.

Search Interest

Only 1 people have searched for HSIC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Henry Schein insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.89% of the stock of Henry Schein is held by insiders.

Percentage Held by Institutions

96.62% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 9/12/2026
• 2026 Global Healthcare Conference: 9/15/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Distributors
• Current Symbol: NASDAQ:HSIC
• CIK: 1000228
• Web: www.henryschein.com
• Phone: (631) 843-5500
• Fax: 631-843-5541
• Employees: 25,000
• Year Founded: 1932

Price Target and Rating

• Average Price Target for Henry Schein: $92.93
• High Price Target: $112.00
• Low Price Target: $64.00
• Potential Upside/Downside: +5.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.53
• Research Coverage: 15 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.43
• Trailing P/E Ratio: 25.76
• Forward P/E Ratio: 16.49
• P/E Growth: 1.67
• Net Income: $398 million
• Net Margins: 2.96%
• Pretax Margin: 4.07%
• Return on Equity: 15.97%
• Return on Assets: 5.56%

Debt

• Debt-to-Equity Ratio: 0.60
• Current Ratio: 1.32
• Quick Ratio: 0.73

Sales & Book Value

• Annual Sales: $13.18 billion
• Price / Sales: 0.75
• Cash Flow: $7.88 per share
• Price / Cash Flow: 11.22
• Book Value: $33.12 per share
• Price / Book: 2.67

Miscellaneous

• Outstanding Shares: 111,450,000
• Free Float: 110,455,000
• Market Cap: $9.85 billion
• Optionable: Optionable
• Beta: 0.81